|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
1998-8-31
|
|
pubmed:abstractText |
Intravesical bacille Calmette-Guérin (BCG) induces a variety of cytokines into the urine of patients with superficial transitional cell carcinoma (TCC) of the bladder. Recent data have shown that some cytokines have antiangiogenic activity. We sought to determine whether the potently antiangiogenic chemokine interferon-inducible protein 10 (IP-10) and its inducing antiangiogenic cytokines, interferon-gamma (IFN-gamma) and interleukin-12 (IL-12), are increased during intravesical BCG immunotherapy of bladder TCC.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
0090-4295
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
52
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
268-75; discussion 275-6
|
|
pubmed:dateRevised |
2008-11-21
|
|
pubmed:meshHeading |
pubmed-meshheading:9697793-Administration, Intravesical,
pubmed-meshheading:9697793-BCG Vaccine,
pubmed-meshheading:9697793-Carcinoma, Transitional Cell,
pubmed-meshheading:9697793-Chemokine CXCL10,
pubmed-meshheading:9697793-Chemokines, CXC,
pubmed-meshheading:9697793-Humans,
pubmed-meshheading:9697793-Interferon-gamma,
pubmed-meshheading:9697793-Interleukin-12,
pubmed-meshheading:9697793-Tumor Cells, Cultured,
pubmed-meshheading:9697793-Urinary Bladder Neoplasms
|
|
pubmed:year |
1998
|
|
pubmed:articleTitle |
Intravesical bacille Calmette-Guérin induces the antiangiogenic chemokine interferon-inducible protein 10.
|
|
pubmed:affiliation |
Department of Surgery, Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|
